|
Canada-0-MATTRESSES Azienda Directories
|
Azienda News:
- Leadership - Novavax
Silvia Taylor Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
- Novavax - Wikipedia
In April 2025, Novavax was still in the process of obtaining full licensure for its COVID-19 vaccine, having submitted a Biologics License Application to the FDA, who requested Novavax complete an additional clinical trial
- Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings
After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs says the company is at a pivot point In February 2023, Novavax warned investors that it might not be able to continue operations for another year
- Novavax CEO and Key Executive Team - Craft. co
Novavax's Director, President and Chief Executive Officer is Stanley C Erck Other executives include Frank Czworka, Senior Vice President, Global Sales, Trade Distribution; Rick Crowley, Executive Vice President, Chief Operations Officer and 27 others See the full leadership team at Craft
- Who is the CEO of Novavax (NVAX)? - financecharts. com
Novavax, Inc (NVAX) is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases
- Novavax Names John C. Jacobs as New President CEO - LinkedIn
Novavax Names John C Jacobs as New President CEO * Current President CEO Stan Erck to retire * Novavax is well-positioned to execute on its strategy, with global authorizations for its
- NVAX | Novavax Inc. Company Profile Executives - WSJ
Company profile for Novavax Inc including key executives, insider trading, ownership, revenue and average growth rates View detailed NVAX description address
- John C. Jacobs | Novavax
John C Jacobs joined Novavax as president and chief executive officer, and a member of the board of directors, in January 2023 He is a seasoned industry leader who has more than 25 years of commercial, operations, business and leadership experience across multiple therapeutic areas
- Novavax CEO Stanley Erck to retire this month
Novavax announced Monday that John Jacobs has been appointed to succeed Stanley Erck as president and CEO of the vaccine maker starting January 23 The company said Erck, who has led the company fo
- Novavax Names John C. Jacobs as New President Chief Executive Officer . . .
Novavax Names John C Jacobs as New President Chief Executive Officer Current President CEO Stanley C Erck will retire effective January 23 with plans to support the leadership transition in an advisory capacity
|
|